Purinergic Regulation of Respiratory Diseases: 55 (Subcellular Biochemistry, 55) - Image 1

£97.00

Springer Purinergic Regulation of Respiratory Diseases: 55 (Subcellular Biochemistry, 55)

Name: Purinergic Regulation of Respiratory Diseases: 55 (Subcellular Biochemistry, 55)
Brand: Springer
Price: 97.0 GBP
Availability: InStock

Pharmacy - Dispensing

Price History & Forecast

Last 19 days • 19 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 19 days • 1 price levels

Days at Price

Price Analysis

Most common price: £97 (19 days, 100.0%)

Price range: £97 - £97

Price levels: 1 different prices over 19 days

Description

Product Description We proudly present the first book to integrate all aspects of purinergic signaling in the respiratory system. The first chapters introduce basic notions of purinergic pharmacology and metabolism, which allows readers from all scientific backgrounds to fully grasp the importance of these signaling networks for airway defenses, including mucociliary clearance and inflammatory responses. Then, chapters are devoted to the groundbreaking discovery that chronic respiratory diseases, including asthma, cystic fibrosis and chronic obstructive pulmonary disease (COPD), present specific aberrances in purinergic signaling which essentially drive lung complications. The last chapters describe the animal models used to investigate purinergic signaling in respiratory diseases, and the therapeutic applications developed by the pharmaceutical industry based on receptor agonists/antagonists and metabolic correctors. This highly comprehensive manuscript constitutes an invaluable tool for beginners and experts to follow the rapidly evolving research field of purinergic signaling. Furthermore, the critical analysis of past clinical protocols should facilitate the identification of potent therapeutic targets, and provide a better understanding of the data acquired in current clinical trials. From the Back Cover We proudly present the first book to integrate all aspects of purinergic signaling in the respiratory system. The first chapters introduce basic notions of purinergic pharmacology and metabolism, which allows readers from all scientific backgrounds to fully grasp the importance of these signaling networks for airway defenses, including mucociliary clearance and inflammatory responses. Then, chapters are devoted to the groundbreaking discovery that chronic respiratory diseases, including asthma, cystic fibrosis and chronic obstructive pulmonary disease (COPD), present specific aberrances in purinergic signaling which essentially drive lung complications. The last chapters describe the animal models used to investigate purinergic signaling in respiratory diseases, and the therapeutic applications developed by the pharmaceutical industry based on receptor agonists/antagonists and metabolic correctors. This highly comprehensive manuscript constitutes an invaluable tool for beginners and experts to follow the rapidly evolving research field of purinergic signaling. Furthermore, the critical analysis of past clinical protocols should facilitate the identification of potent therapeutic targets, and provide a better understanding of the data acquired in current clinical trials.

Product Specifications

Brand: Springer
Format: Hardcover
ASIN: 9400712162
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 12 May 2011
Listed Since: 21 January 2011

Barcode

No barcode data available

Springer Purinergic Regulation of Respiratory Diseases: 55 (Subcellular Biochemistry, 55)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Purinergic Regulation of Respiratory Diseases: 55 (Subcellular Biochemistry, 55)

Pathobiology of Pulmonary Disorders: 955 (Advances in Experimental Medicine and Biology, 955)

Respiratory Regulation - Clinical Advances: 755 (Advances in Experimental Medicine and Biology, 755)

Lung Inflammation in Health and Disease, Volume I: 1303 (Advances in Experimental Medicine and Biology, 1303)

Respiratory System Diseases: 980 (Advances in Experimental Medicine and Biology, 980)

Advances in Pulmonary Medicine: Research and Innovations: 1160 (Advances in Experimental Medicine and Biology, 1160)

Pulmonary Biology in Health and Disease

Pulmonary Disorders and Therapy: 1023 (Advances in Experimental Medicine and Biology, 1023)

Pulmonology: 1222 (Advances in Experimental Medicine and Biology, 1222)

Targeting Cellular Signalling Pathways in Lung Diseases

Purinergic Approaches in Experimental Therapeutics

Respirology: 885 (Advances in Experimental Medicine and Biology, 885)

Pathophysiology of Respiration: 884 (Advances in Experimental Medicine and Biology, 884)

Purinergic Signaling: Methods and Protocols: 2041 (Methods in Molecular Biology, 2041)

Springer - Targeting Cellular Signalling Pathways in Lung Diseases

Chronic Lung Diseases: Pathophysiology and Therapeutics

Advances in Clinical Science: 878 (Advances in Experimental Medicine and Biology, 878)

Purinergic Signaling in Neuroinflammation

Molecular Basis of Pulmonary Disease: Insights from Rare Lung Disorders (Respiratory Medicine)

Pediatric Pulmonology

Lung Inflammation in Health and Disease, Volume II: 1304 (Advances in Experimental Medicine and Biology, 1304)

Clinical Research Involving Pulmonary Disorders: 1040 (Advances in Experimental Medicine and Biology, 1040)

Pulmonary Infection and Inflammation: 935 (Advances in Experimental Medicine and Biology, 935)

The Microbiome in Respiratory Disease: Principles, Tools and Applications (Respiratory Medicine)